Introduction
============

Penile implants have become relatively common in the treatment of erectile dysfunction. Although penile prosthetics date back to the 16th century, modern implants were first introduced in 1973 and 1974 when Dr. Scott and Drs. Small and Carrion described what are now referred to inflatable and semi rigid penile prosthesis respectively ([@r1]). Since then there have been significant design improvements, and today patients have the choice of semi rigid, 2-piece and 3-piece penile prosthetics. In the modern era, it is estimated that approximately 25,000 penile prosthesis are implanted in North America annually ([@r2]). One of the most significant complications of penile prosthetic surgery is infection, and the implant surgeon must be aware of potential sources of infection. The goal of penile prosthetic surgery is to provide the patient with a functional erection for sexual intercourse while keeping morbidity low. In this review we will discuss important aspects of the medical history and provide a simple and practical checklist for the implanter to reference when considering implantation of a penile prosthesis.

Medical history pertaining to penile implant surgery
====================================================

The past medical and past surgical histories are a crucial component of any patient encounter. Most patients seeking treatment for erectile dysfunction (ED) will have other medical comorbidities that can impact the success of prosthetic surgery. ED is often associated with vascular disease and diabetes mellitus, and prior medical evaluation is often warranted before surgical intervention is considered. We pay special attention to antiplatelet (AP) and anticoagulant (AC) use, previous abdominal and inguinal surgery, diabetic history, use of steroids and history of spinal cord injury.

Antiplatelet and anticoagulant use and optimization
---------------------------------------------------

Erectile dysfunction is more common in an elderly population and is often occurs in the presence comorbid of cardiovascular disease. A diagnosis of ED is often a marker of underlying coronary artery disease, even in younger patients, and places this population at a higher risk of future cardiovascular events including myocardial infarction and stroke ([@r3],[@r4]). We recommend medial consolation and evaluation for cardiovascular disease if the patient has not already done so. As a result of comorbid disease, patients seeking surgical treatment may be taking therapeutic of prophylactic doses of AP or AC medications. The American Urologic Association classifies penile prosthetic surgery as high risk for bleeding, necessitating a careful medication review ([@r5]). Medical conditions requiring these classes of medication include congestive heart failure, coronary stents, atrial fibrillation, mechanical heart valves, and deep vein thrombosis or pulmonary embolus. Because prosthetic surgery is elective, many patients should wait until they are off anticoagulation before implantation. Dual Antiplatelet Therapy (DAPT) should be continued for at least 30 days after a bare metal stent, and for at least 12 months after a drug-eluting stent. In some cases, discontinuing or waiting to discontinue AP/AC is not possible. The AUA and EAU have developed guidelines to aid in patient selection ([@r6],[@r7]). Despite these guidelines, the risk of hemorrhage or thrombosis must be carefully weighed, and medical consultation should always be considered before discontinuation of AC/AP. In our institution we are comfortable operating on patients taking aspirin 81 mg. If the patient needs to be on clopidogrel or another anticoagulant we will place a drain close to the corpora cavernosa that exits out of inguinal area and remove 7 days after surgery ([*Table 1*](#t1){ref-type="table"}).

###### Summary of AP/AC recommendations from the AUA

  Condition                                Guideline
  ---------------------------------------- ----------------------------------------------------------------
  Bare metal stents                        Dual therapy for 1 month
  Drug eluting stents                      Dual therapy for 12 months
  Atrial fibrillation requiring Warfarin   Consult cardiology, stop 5 days prior, restart in 12--24 hours
  Mechanical valve                         Cardiology consultation

Antiplatelet recommendations for penile prosthetics. Discontinuation of dual therapy. cardiology consultation, discontinue 10 days prior, restart within 7--10 days.

Previous abdominal surgery
--------------------------

Prior abdominal surgery can be predictive of intraoperative difficulty, specifically in regard to reservoir placement. Open radical prostatectomy had the advantage of keeping the space of Retzius intact. Robotic assisted laparoscopic prostatectomy (RALP) has become the surgical treatment of choice for prostate cancer, but has made reservoir placement more challenging because the space of Retzius can be compromised. When interviewing patients we pay particular attention to a history of RALP, radical cystectomy, and inguinal hernia repair. In these situations, we choose to place the reservoir in a submuscular location ([@r8]). Recent review of submuscular, below the internal oblique but above the transversalis fascia, reservoir placement have proven this technique to be a safe and effective alternative with high patient satisfaction ([@r9],[@r10]). Inguinal surgeries, such as prior hernia repair with mesh, can also make traditional reservoir placement more complicated, and when possible we choose to place the reservoir on the side opposite the hernia repair. In cases of bilateral inguinal hernia repair we will consider submuscular placement of the reservoir. Men need to be warned about the possibility of a palpable reservoir and the rare possibility of herniation of the reservoir.

DM and HbA1c optimization, steroid use and spinal cord injury patients
----------------------------------------------------------------------

Classically diabetics have been considered a high risk patient group for complications related to infection ([@r11]-[@r13]). Reasonable evidence suggested that poorly controlled diabetes with Hbg A1c greater than 11.5, posed significant risk to infection and future *explanation* ([@r11],[@r12],[@r14]). More contemporary meta-analysis data has changed opinion, showing similar rates of infection between diabetics, poorly controlled diabetics and non-diabetics ([@r15]) ([*Table 2*](#t2){ref-type="table"}). Despite this, we still ask that pts with hemoglobin A1c greater than 10 to optimize their diabetic control prior implantation.

###### Summary of modern studies comparing the rate of penile prosthetic infection in diabetic (DM) and non-diabetic patients

  Studies                           Patient number   Follow up    Diabetics   DM infection rate   Non DM infection rate   Significant
  --------------------------------- ---------------- ------------ ----------- ------------------- ----------------------- -------------
  Song *et al.* 2013 ([@r16])       224              10 y         9           0.5                 0                       N
  Chung *et al.* 2013 ([@r17])      955              30 y         229         2                   3.6                     N
  Mulcahy *et al.* 2011 ([@r13])    31,341           2001--2008   6,695       1.7                 1.26                    Y
  DiBlasio *et al.* 2010 ([@r18])   79               1997--2007   43          9.3                 2.7                     Y
  Wilson *et al.* 2007 ([@r19])     467              3 y          83          1                   0                       N
  Montague *et al.* 2001 ([@r20])   491              1986--1999   137         2.2                 2                       N
  Wilson *et al.* 1998 ([@r11])     389              1994--1996   114         8.8                 4                       Y

Diabetics and prosthetic infections.

Unfortunately, unlike diabetics, there continues to be strong evidence suggesting that chronic steroid use and spinal cord injury increase patient's infection risk. Whenever possible, we prefer to delay surgery until patients have discontinued steroid use ([@r19]). For spinal cord injury patients, we counsel them on the additional infection risk because of urine stasis and complications from neurogenic bladder requiring intermittent catheterizations ([@r15],[@r19]).

Preoperative considerations
===========================

Preoperative prophylactic antibiotics
-------------------------------------

Even though penile implants generally have a low morbidity, the most devastating complication is infection. The majority of perioperative considerations focus on decreasing the incidence of infection. Overall, infections affect around 3% of penile implants during the first year after surgery, with this rate being increased for revision surgeries ([@r20],[@r21]). In attempts to minimize post-operative infection, prophylactic antibiotics have been studied and shown to be efficacious. While there have been no studies specifically investigating home oral antibacterial prophylaxis for penile implants, there have been extensive studies on orthopedic implants and hernia mesh surgeries ([@r22],[@r23]). Multiple studies of penile implantation mention the use of preoperative prophylactic antibiotic, but are not directly investigated ([@r24]). We recommend prophylactic preoperative antibiotics (2 days of Bactrim or Ciprofloxacin) for all patients undergoing penile implant surgery.

Urinalysis and urine culture
----------------------------

At our institution we obtain preoperative urine cultures because we routinely place Foley catheters prior to surgery for the purpose of identification of the urethra intra operatively, decompression of the bladder, and to allow for 24 hours of bedrest post operatively. The use of a preoperative urinalysis and culture is theoretically useful to identify a potential source for bacteremia, and thus a potential prosthesis infection ([@r25]). Despite this, studies of orthopedic procedures, treating positive urinalysis and culture made no difference in infection rates ([@r26]-[@r28]). There are no studies to show a reduction in prosthetic infections when treating asymptomatic bacteruria. Cultures of infected prosthesis show skin flora, like Staphylococcus epidermidis, are the most common organisms ([@r25],[@r26]). Despite there being a lack of evidence, approximately 50-60% of implanters still routinely obtain preoperative urine cultures ([@r29]).

Preoperative scrotal wash with Chlorhexidine wash
-------------------------------------------------

There is no data specifically investigating the use of washes prior to penile prosthetic implantation as a means to reduce infection. There is evidence from orthopedic surgery literature so suggest a reduction in surgical site infection when patient used chlorhexidine impregnated washes at home the day prior to surgery ([@r30]) We recommend Hibiclens (4% w/v chlorhexidine gluconate) skin wash to use starting 2 days prior to surgery.

Hair removal
------------

Hair removal technique in penile prosthetic surgery is believed to be a potential risk for infection from skin flora, despite any robust evidence. We ask that out patients not to shave, or clip themselves before surgery. General surgery literature suggests clippers are the preferable method of hair removal in the preoperative setting. However because of the delicate, irregular, and elastic skin of the male genitalia urologists have preferred razors for hair removal. Grober *et al*. compared 215 patients undergoing genital surgery to either razor (108 patients) or clipper (107 patients) perioperative hair removal without showing a difference in surgical site infection (two in razor *vs.* two in clipper) ([@r31]). In the absence of any evidence to the contrary, the Sexual Medicine Society of North America recommends that surgeons be permitted their choice of razors or clippers for preoperative preparation of the male genitalia ([@r32]).

Operative considerations
========================

Intraoperative antibiotics
--------------------------

As with all open surgical procedures, antibiotics at the time of incision are mandatory. Advances in penile prosthetics have included proprietary antibiotic and hydrophilic coatings that have reduced overall infection rates, however preoperative antibiotics are still recommended ([@r33],[@r34]). The AUA currently recommends perioperative use of an aminoglycoside (or aztreonam) and a first or second generation cephalosporin or vancomycin, which might be continued up to 24 h after surgery ([@r33]). Acceptable alternative antibiotics include ampicillin/*sulbactam*, ticarcillin/clavulanate, and *piperacillin*/*tazobactam* for less than 24 hours if no previous bacterial colonization. Survey data among implanters shows significant variety of first choice preoperative antibiotics ([@r35]). When there is no contraindication we use Vancomycin 1 g and Gentamicin 160 mg IV. The vancomycin is started in the preoperative area as infusion takes 60 minutes to complete while the gentamicin is infused during time out. We continue both medications for 24 h post operatively.

Skin preparation
----------------

Careful skin preparation is critical for successful implantation and prevention of contamination from skin flora. It is believed that the primary route of implant infections occur before or during the implantation, and elimination of skin flora through proper skin antisepsis will reduce implant infection rates ([@r34])

Historically, *povidone*-iodine has been the prep of choice while chlorhexidine-alcohol scrubs were not utilized due lack of evidence of superiority, and concerns of urethral irritation. Nevertheless, recent evidence now suggests chlorhexidine to be the superior scrub. Darouiche *et al.* showed that the overall rate of surgical site infection was significantly lower in the chlorhexidine-alcohol group than the povidone-iodine group ([@r36]) This was again later confirmed by Yeung *et al.* ([@r37]). In addition to concluding that chlorhexidine was a superior scrub compared to iodine in the eradication of skin flora of the surgical site, they noted that there was no urethral complications or genital complications associated with either prep peri-operatively or postoperatively ([@r38]). With lower infection rate incidence and no significant irritation of the genitalia, we prefer to use a chlorhexidine based prep ([*Table 3*](#t3){ref-type="table"}).

###### Summary of studies comparing preoperative chlorhexidine and iodine based skin preparation

  Study                              Surgery type                 Time frame         Patient number      Outcome measure
  ---------------------------------- ---------------------------- ------------------ ------------------- ---------------------------
  Darouiche *et al.* 2010 ([@r36])   Clean contaminated           30 days            Chlorhexidine 409   9.5% infection rate
  Iodine 440                         16.1% infection rate                                                
  Yeung *et al.* 2013 ([@r37])       Penile prosthetics           Mean 9.75 months   Chlorhexidine 50    8% positive skin cultures
  Iodine 50                          32% positive skin cultures                                          

Chlorhexidine *vs.* iodine

No touch technique
------------------

Even with careful skin antisepsis, pre-and post-operative antibiotic regimens, irrigation of the surgical field with antimicrobial solution, and the use of antibiotic coated devices, prosthetic infections occur at unacceptably high rates. With room for improvement, a goal became to find new ways to reduce skin flora contamination. In 2011, Eid presented the "no-touch" technique for IPP surgery. The technique builds off of the traditional approach through the penoscrotal raphe until the level of Buck's fascia is reached. To reduce skin contamination, all surgical instruments and gloves that have been used until this point are considered unclean and removed from the field. New, unused instruments and gloves are then utilized to cover the surgical field with a clear drape. Above the original incision site, the surgeon creates a small opening in the drape and then performs the remainder of the implant procedure through the drape. This allows the surgeon to avoid contact with the original surgical site. The focus of this technique is to avoid all contact with the patient's skin, the surgeon's hands, the surgical instruments, and the implant, reducing the risk of contamination and infection ([@r24],[@r39]). A single surgeon study showed that performing the no-touch technique with antibiotic coated penile prosthesis reduced his infection rate to 0.44% from a previous rate of 1.67% when compared to the standard technique (P=0.0042) ([@r39]). There are downsides that include increasing operating time by 10 minutes as well as the additional cost incurred due to the requirement of additional instruments and supplies ([@r39]) The procedure is rather new and there is limited data on the technique's efficacy in reducing infection rates, and whether it is worth the additional costs to perform.

Conclusions
===========

Penile prosthesis impanation is an effective treatment for erectile dysfunction. A thorough medical and surgical history is a critical part of the preoperative workup. There are established guidelines for the management of antiplatelet and anticoagulation. Much of what we understand about prevention of prosthetic infections is extrapolated from orthopedic and general surgery literature leading to significant heterogeneity among surgical preparation and techniques. Randomized clinical trials comparing preoperative antibiotics do not exist and are unlikely to be undertaken. After reviewing the literature and our own practice, we propose a simple preoperative checklist that may be utilized by the implant surgeon. [*Figure 1*](#f1){ref-type="fig"}. We recommend using a consistent preoperative preparation that the surgeon is comfortable with when approaching penile implant surgery.

![Proposed checklist for penile implantation.](tau-06-S5-S824-f1){#f1}
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